Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hurwitz

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
The Annals of Pharmacotherapy|March 24, 2005
Successful desensitization to oxaliplatinLydia Mis, Nishan H Fernando, Hurbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trialsFairooz F Kabbinavar, Herbert I Hurwitz, Jing Yi, et al.
The American Journal of Clinical Nutrition|June 1, 1982
The effects of infantile malnutrition on behavioral development: a follow-up studyW R Beardslee, P H Wolff, I Hurwitz, et al.
Computers in Biology and Medicine|January 2, 2015
A leave-one-out cross-validation SAS macro for the identification of markers associated with survivalChristel Rushing, Anuradha Bulusu, Herbert I Hurwitz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2012
Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorinCody J Peer, Terence J McManus, Herbert I Hurwitz, et al.
Biochemical and Biophysical Research Communications|October 27, 1975
On the tertiary structure of tropomysin tactoidsA G Walton, C R McMillin, H J Weintraub, et al.
The Oncologist|January 16, 2009
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancerHerbert I Hurwitz, Jing Yi, William Ince, et al.
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Journal of Neurophysiology|April 1, 1996
Activity patterns of the B31/B32 pattern initiators innervating the I2 muscle of the buccal mass during normal feeding movements in Aplysia californicaI Hurwitz, D Neustadter, D W Morton, et al.
Preventive Medicine|September 1, 1981
A psychosocial model of smoking cessation and maintenance of cessationJ K Ockene, R Nutall, R C Benfari, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
The Annals of Pharmacotherapy|March 24, 2005
Successful desensitization to oxaliplatinLydia Mis, Nishan H Fernando, Hurbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trialsFairooz F Kabbinavar, Herbert I Hurwitz, Jing Yi, et al.
The American Journal of Clinical Nutrition|June 1, 1982
The effects of infantile malnutrition on behavioral development: a follow-up studyW R Beardslee, P H Wolff, I Hurwitz, et al.
Computers in Biology and Medicine|January 2, 2015
A leave-one-out cross-validation SAS macro for the identification of markers associated with survivalChristel Rushing, Anuradha Bulusu, Herbert I Hurwitz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2012
Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorinCody J Peer, Terence J McManus, Herbert I Hurwitz, et al.
Biochemical and Biophysical Research Communications|October 27, 1975
On the tertiary structure of tropomysin tactoidsA G Walton, C R McMillin, H J Weintraub, et al.
The Oncologist|January 16, 2009
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancerHerbert I Hurwitz, Jing Yi, William Ince, et al.
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Journal of Neurophysiology|April 1, 1996
Activity patterns of the B31/B32 pattern initiators innervating the I2 muscle of the buccal mass during normal feeding movements in Aplysia californicaI Hurwitz, D Neustadter, D W Morton, et al.
Preventive Medicine|September 1, 1981
A psychosocial model of smoking cessation and maintenance of cessationJ K Ockene, R Nutall, R C Benfari, et al.
Pageof 19